VTE
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1. Patients with a definitive diagnosis of malignant tumor confirmed by histopathology. 2. Patients may be at any stage (treatment, monitoring, or recurrence) at the time of initial study enrollment. 3. Age >=18 years. 4. Visited Henan Cancer Hospital between January 1, 2017, and March 31, 2024.
Exclusion criteria
Exclusion criteria: 1. Patients who were discharged automatically or did not receive any anti-malignant tumor treatment due to non-thrombotic factors. 2. No histopathological diagnostic basis. 3. Incomplete clinical data or follow-up information. 4. Life expectancy of no more than 12 weeks due to concomitant severe underlying diseases such as cardiovascular or cerebrovascular conditions.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| venous thrombosis;Calibration curves;Decision curve analysis; | — |
Secondary
| Measure | Time frame |
|---|---|
| Receiver operating characteristic curves ; | — |
Countries
China
Contacts
The Affiliated Cancer Hospital of Zhengzhou University & Henan Cancer Hospital